Strongyloidiasis history and symptoms

Revision as of 15:29, 10 December 2012 by Prashanthsaddala (talk | contribs)
Jump to navigation Jump to search

Strongyloidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Strongyloidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Strongyloidiasis history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Strongyloidiasis history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Strongyloidiasis history and symptoms

CDC on Strongyloidiasis history and symptoms

Strongyloidiasis history and symptoms in the news

Blogs on Strongyloidiasis history and symptoms

Directions to Hospitals Treating Strongyloidiasis

Risk calculators and risk factors for Strongyloidiasis history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

History and Symptoms

Strongyloides infection occurs in five forms. On acquiring the infection, there may be respiratory symptoms (Löffler's syndrome). The infection may then become chronic with mainly digestive symptoms. On reinfection (when larvae migrate through the body), there may be respiratory, skin and digestive symptoms. Finally, the hyperinfection syndrome causes symptoms in many organ systems, including the central nervous system.[1][2]

Uncomplicated disease

Frequently asymptomatic. Gastrointestinal system symptoms include abdominal pain and diarrhea. Pulmonary symptoms (including Löffler's syndrome) can occur during pulmonary migration of the filariform larvae. Dermatologic manifestations include urticarial rashes in the buttocks and waist areas. Blood eosinophilia is generally present.

Strongyloidiasis can become chronic and then become completely asymptomatic.

Disseminated disease

Disseminated strongyloidiasis occurs when patients with chronic strongyloidiasis become immunosuppressed. It presents with abdominal pain, distension, shock, pulmonary and neurologic complications and septicemia, and is potentially fatal. The worms enter the bloodstream from the bowel wall, simultaneously allowing entry of bowel bacteria such as Escherichia coli. This may cause symptoms such as sepsis (bloodstream infection),[citation needed] and the bacteria may spread to other organs where they may cause localized infection such as meningitis.[3]

Dissemination can occur many decades after the initial infection[4] and has been associated with high dose corticosteroids, organ transplant, HIV,[5][6] lepromatous leprosy, tertiary syphilis, aplastic anemia, malnutrition, advanced tuberculosis and radiation poisoning.[7] It is often recommended that patients being started on immunosuppression be screened for chronic strongyloidiasis; however, this is often impractical (screen tests are often unavailable) and in developed countries, the prevalence of chronic strongyloidiasis is very small, so screening is usually not cost-effective, except in endemic areas.

Gastrointestinal

Pulmonary

Pulmonary symptoms (including Loeffler’s syndrome) can occur during pulmonary migration of the filariform larvae.

Skin

Dermatologic manifestations include urticarial rashes in the buttocks and waist areas. Disseminated strongyloidiasis occurs in immunosuppressed patients, can present with Abdominal Pain, abdominal distension, shock, pulmonary and neurologic complications and septicemia, and is potentially fatal.

References

  1. Montes M, Sawhney C, Barros N (2010). "Strongyloides stercoralis: there but not seen". Curr Opin Infect Dis. 23 (5): 500–4. doi:10.1097/QCO.0b013e32833df718. PMC 2948977. PMID 20733481. Unknown parameter |month= ignored (help)
  2. Marcos LA, Terashima A, Dupont HL, Gotuzzo E (2008). "Strongyloides hyperinfection syndrome: an emerging global infectious disease". Trans R Soc Trop Med Hyg. 102 (4): 314–8. doi:10.1016/j.trstmh.2008.01.020. PMID 18321548. Unknown parameter |month= ignored (help)
  3. Graeff-Teixeira C, da Silva AC, Yoshimura K (2009). "Update on Eosinophilic Meningoencephalitis and Its Clinical Relevance". Clinical Microbiology Reviews. 22 (2): 322–48. doi:10.1128/CMR.00044-08. PMC 2668237. PMID 19366917. Unknown parameter |month= ignored (help)
  4. Gill GV, Beeching NJ, Khoo S; et al. (2004). "A British Second World War veteran with disseminated strongyloidiasis". Trans R Soc Trop Med Hyg. 98 (6): 382–6. doi:10.1016/j.trstmh.2003.11.002. PMID 15099996.
  5. Kramer MR, Gregg PA, Goldstein M, Llamas R, Krieger BP. (1990). "Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage". South Med J. 83 (10): 1226–9. doi:10.1097/00007611-199010000-00024. PMID 2218668.
  6. Gompels MM, Todd J, Peters BS, Main J, Pinching AJ. (1991). "Disseminated strongyloidiasis in AIDS: uncommon but important". AIDS. 5 (3): 329–32. doi:10.1097/00002030-199103000-00015. PMID 2059374.
  7. Purtilo DT, Meyers WM, Connor DH (1974). "Fatal strongyloidiasis in immunosuppressed patients". Am J Med. 56 (4): 488–93. doi:10.1016/0002-9343(74)90481-1. PMID 4818417.